Pipelines
We have established a portfolio of promising pipelines targeting immune cells to combat neurodegenerative diseases. Our selection criteria include technical novelty, unmet medical need, safety, and accelerated path to clinical trials.
NiT-2
NiT-2 utilizes innovative technology to engineer immune cells from the bloodstream, enhancing the immune response in the nervous system. This groundbreaking approach aims to prevent the development of neurological disorders, including synucleinopathy, by bolstering the body’s natural defenses.